Trust CO Of Vermont Tekla Life Sciences Investors Transaction History

Trust CO Of Vermont

$2.01 Billion
Q4 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 02, 2018	SELL	$18.31 - $22.24 $4,559 - $5,537	-249 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$20.12 - $21.88 $5,009 - $5,448	249	249 $5,000

Others Institutions Holding HQL

# of Institutions

78

Shares Held

9.65M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$48.6 Million
1.11% of portfolio
Penserra Capital Management LLC Orinda, CA

828K
Shares

$11.7 Million
0.2% of portfolio
Karpus Management, Inc. Pittsford, NY

490K
Shares

$6.94 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.91 Million
0.12% of portfolio
Absolute Investment Advisers LLC

400K
Shares

$5.66 Million
0.67% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.